H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12.8% of adults in Fort Lauderdale have diagnosed diabetes — 0.8 points above the U.S. 12% figure. Census population 182,760. Florida Medicare wound biologics: First Coast Service Options (JN). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Fort Lauderdale clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Fort Lauderdale storefront.
Skin Substitute Therapy Products in Fort Lauderdale, FL for clinics & physicians. Skin substitute therapy… Compliance support & pricing — contact Hawk Medical.
Fort Lauderdale is a city under 250k (182,760 Census). CDC PLACES (2023, crude) estimates 12.8% of adults in Fort Lauderdale have diagnosed diabetes — 0.8 points above the U.S. 12% figure. Adult arthritis here is 24.4% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National Skin Substitute Therapy Products notes (how the product actually works)CDC PLACES (2023, crude) estimates 12.8% of adults in Fort Lauderdale have diagnosed diabetes — 0.8 points above the U.S. 12% figure. Adult obesity in Fort Lauderdale is 30.3% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 24.4% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JN / First Coast Service Options, sibling states no other states. Florida Department of Health is the public-health home. We will not mash those grains into a fake “demand score.”
Vendor consolidation is boring on purpose: one account, IFUs filed, JN articles mapped. 14.7% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 12.8% of adults — 0.8 points above the U.S. 12% figure. Obesity is 30.3%; arthritis is 24.4%. That is place-level BRFSS modeling, not a clinic census and not a Fort Lauderdale trial.
We source from FDA-registered banks. Bank location is not the same as Hawk Medical’s distribution address, and it is not a Fort Lauderdale clinic. Ask for the bank’s registration and AATB status on the SKU you want.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what JN reviewers and surveyors expect — not a brochure.
No. Hematogel is a PRP-based wound gel pathway with its own application and documentation. Skin substitutes/CTPs follow First Coast Service Options CTP articles. Mixing those codes is a billing error.
If you operate in Florida and another MAC state, say it on the first call. JN will not port 1:1. We would rather split utilization than watch a sister clinic copy Fort Lauderdale tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Fort Lauderdale, FL.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Fort Lauderdale is JN geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Fort Lauderdale — 0.8 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Florida Part B wound biologics follow this contractor (siblings: no other states). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Fort Lauderdale. Useful for joint-program math; still needs a diagnosis and privileging.
No Fort Lauderdale storefront. Joe Bradley is an active practice owner. skin substitute therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.